Rehmann Capital Advisory Group’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-766	Closed	-$218K	–	513
2022 Q1	$218K	Sell	766 -22	-3%	-$6.78K	0.02%	485
2021 Q4	$297K	Buy	788 +27	+4%	+$10.5K	0.03%	438
2021 Q3	$314K	Buy	761 +1	+0.1%	+$415	0.03%	425
2021 Q2	$283K	Buy	760 +10	+1%	+$3.34K	0.03%	444
2021 Q1	$217K	Sell	750 -139	-16%	-$38.6K	0.02%	480
2020 Q4	$222K	Buy	889 +3	+0.3%	+$714	0.03%	448
2020 Q3	$201K	Buy	+886	New	+$184K	0.03%	410
2019 Q3	$81.5K	Buy	616 +221	+56%	+$29.6K	0.01%	502
2019 Q2	$56K	Sell	395 -1	-0.3%	-$136	0.01%	791
2019 Q1	$57.5K	Sell	396 -36	-8%	-$4.73K	0.01%	769
2018 Q4	$48.9K	Buy	432 +34	+9%	+$4.26K	0.01%	594
2018 Q3	$53.5K	Sell	398 -4	-1%	-$494	0.01%	767
2018 Q2	$45.1K	Buy	402 +300	+294%	+$32.4K	0.01%	819
2018 Q1	$11K	Buy	+102	New	+$11K	﹤0.01%	1273